| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |